Horse Chestnut for Vein Health: A Research Review

The Most-Studied Botanical for Vein Health

Horse Chestnut Seed Extract (HCSE) is the most clinically researched botanical for venous insufficiency, with a body of evidence substantial enough to earn a Cochrane systematic review.

Active Compound: Aescin

Aescin is a mixture of triterpenoid saponins that inhibit lysosomal enzymes — hyaluronidase and elastase — responsible for breaking down capillary walls and connective tissue in venous walls. By preserving these structures, aescin helps maintain vascular integrity.

What the Cochrane Review Found

A systematic review of 17 trials found HCSE significantly reduced leg pain, edema volume, ankle and calf circumference, and subjective symptom scores compared to placebo. One direct comparison found HCSE comparable to compression stockings for symptom relief.

Mechanism in Detail

Aescin reduces capillary permeability — meaning less fluid leakage into surrounding tissue and therefore less swelling. It also reduces inflammatory signaling in venous walls and improves venous tone.

Standardization and Dosing

Quality products should be standardized to 16-20% aescin content. Typical research dose is 300mg of standardized extract twice daily. Most studies show meaningful improvements at 4-8 weeks.

Safety Profile

HCSE is generally well tolerated; GI effects are the most commonly reported side effect. Raw horse chestnut contains esculin, which is toxic — only standardized extracts with esculin removed are safe. It is not recommended in pregnancy or in severe kidney or liver disease.